Andrey Tolkachev Dermatology drug developer Azitra (AZTR) has barely upsized its proposed preliminary public providing to $20M. Azitra …
Andrey Tolkachev Dermatology drug developer Azitra (AZTR) has barely upsized its proposed preliminary public providing to $20M. Azitra …
Already a subscriber? Log in
